Literature DB >> 9973016

Clinical course of persistent junctional reciprocating tachycardia.

P C Dorostkar1, M J Silka, F Morady, M Dick.   

Abstract

OBJECTIVE: The purpose of this study is to review the clinical course of persistent junctional reciprocating tachycardia (PJRT) in 21 patients spanning a wide age range to examine the electrophysiologic characteristics of the conduction system in these patients with PJRT, particularly in regards to its incessant nature and to evaluate the long-term response to radiofrequency ablation.
BACKGROUND: Persistent junctional reciprocating tachycardia is uncommon, occurring in 1% of patients with supraventricular tachycardia. Its presentation, course and treatment are incompletely characterized.
METHODS: The clinical, electrocardiographic, electrophysiologic and echocardiographic data of 21 patients with PJRT were reviewed.
RESULTS: In 9 of these 21 patients, the mean tachycardia cycle length increased significantly (p < 0.0001) as the patients grew, from a mean tachycardia cycle length of 308+/-64 ms in the patients less than 2 years, 414+/-57 ms in the patients between 2 years and 5 years, to 445+/-57 ms in the patients greater than 5 years, primarily due to slowing of retrograde conduction in the accessory pathway. Persistent junctional reciprocating tachycardia was associated with impaired ventricular function in 11, improving spontaneously in 4 and, after successful ablation of the accessory pathway, in 7. All patients except one were uncontrolled on one or more medications. Ablation of the accessory pathway was successful in 19 of 21 patients.
CONCLUSIONS: We conclude that PJRT is characterized by an onset in early childhood and by an age-related prolongation of the tachycardia cycle length mediated primarily through conduction delay in the concealed, retrogradely conducting accessory pathway. Ablation of the accessory pathway provides definitive treatment for PJRT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973016     DOI: 10.1016/s0735-1097(98)00590-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Resolution of tachycardia-induced cardiomyopathy following ablation of verapamil-sensitive idiopathic left ventricular tachycardia.

Authors:  A Arya; M Haghjoo; P Davari; M A Sadr-Ameli
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

2.  Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome.

Authors:  G Vaksmann; C D'Hoinne; V Lucet; S Guillaumont; J-M Lupoglazoff; A Chantepie; I Denjoy; E Villain; F Marçon
Journal:  Heart       Date:  2005-04-14       Impact factor: 5.994

3.  Tachycardia-mediated cardiomyopathy and the permanent form of junctional reciprocating tachycardia.

Authors:  James Michael Bensler; Christopher M Frank; Mehdi Razavi; Abdi Rasekh; Mohammad Saeed; Phillip C Haas; Alireza Nazeri; Ali Massumi
Journal:  Tex Heart Inst J       Date:  2010

4.  Radiofrequency catheter ablation of patients with permanent junctional reciprocating tachycardia and long-term follow-up results.

Authors:  Yalçın Gökoğlan; Veysel Kutay Vurgun; Hasan Kutsi Kabul; Suat Görmel; Salim Yaşar; Serkan Asil; Serdar Fırtına; Erkan Yıldırım; Basri Amasyalı; Sedat Köse
Journal:  J Interv Card Electrophysiol       Date:  2021-09-02       Impact factor: 1.900

5.  [Permanent junctional reciprocating tachycardia causing cardiomyopathy in an adult woman].

Authors:  Dirk Vollmann; Claudius Hansen
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09-07

Review 6.  Neonatal arrhythmias: diagnosis, treatment, and clinical outcome.

Authors:  Ji-Eun Ban
Journal:  Korean J Pediatr       Date:  2017-11-27

7.  Outcomes of sustained fetal tachyarrhythmias after transplacental treatment.

Authors:  Raphael Bartin; Alice Maltret; Muriel Nicloux; Yves Ville; Damien Bonnet; Julien Stirnemann
Journal:  Heart Rhythm O2       Date:  2021-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.